Report Detail

Request for Sample of this report

Pharma & Healthcare Global Adalimumab Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4744937
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Adalimumab Injection market size was valued at US$ 1084 million in 2025 and is forecast to a readjusted size of US$ 1567 million by 2032 with a CAGR of 5.5% during review period.
This report is a detailed and comprehensive analysis for global Adalimumab Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Adalimumab Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Adalimumab Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Adalimumab Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Adalimumab Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Adalimumab Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Adalimumab Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Amgen, Sandoz, Fresenius Kabi, Biogen, Celltrion, Cadila Pharmaceuticals, Bio-Thera Solutions, Ltd., Hisun Biopharmaceutical, Innovent Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Adalimumab Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
40mg/0.8ml
20mg/0.4ml
Market segment by Application
Hospitals
Clinics
Others
Major players covered
AbbVie
Amgen
Sandoz
Fresenius Kabi
Biogen
Celltrion
Cadila Pharmaceuticals
Bio-Thera Solutions, Ltd.
Hisun Biopharmaceutical
Innovent Biologics
Mylan
Zydus Group
Boehringer Ingelheim
Jiangsu Chia Tai-Tianqing Pharmaceutical
Shanghai Henlius Biotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Adalimumab Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Adalimumab Injection, with price, sales quantity, revenue, and global market share of Adalimumab Injection from 2021 to 2026.
Chapter 3, the Adalimumab Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adalimumab Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Adalimumab Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Adalimumab Injection.
Chapter 14 and 15, to describe Adalimumab Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Adalimumab Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 40mg/0.8ml
    • 1.3.3 20mg/0.4ml
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Adalimumab Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Adalimumab Injection Market Size & Forecast
    • 1.5.1 Global Adalimumab Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Adalimumab Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Adalimumab Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie Adalimumab Injection Product and Services
    • 2.1.4 AbbVie Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AbbVie Recent Developments/Updates
  • 2.2 Amgen
    • 2.2.1 Amgen Details
    • 2.2.2 Amgen Major Business
    • 2.2.3 Amgen Adalimumab Injection Product and Services
    • 2.2.4 Amgen Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Amgen Recent Developments/Updates
  • 2.3 Sandoz
    • 2.3.1 Sandoz Details
    • 2.3.2 Sandoz Major Business
    • 2.3.3 Sandoz Adalimumab Injection Product and Services
    • 2.3.4 Sandoz Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sandoz Recent Developments/Updates
  • 2.4 Fresenius Kabi
    • 2.4.1 Fresenius Kabi Details
    • 2.4.2 Fresenius Kabi Major Business
    • 2.4.3 Fresenius Kabi Adalimumab Injection Product and Services
    • 2.4.4 Fresenius Kabi Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Fresenius Kabi Recent Developments/Updates
  • 2.5 Biogen
    • 2.5.1 Biogen Details
    • 2.5.2 Biogen Major Business
    • 2.5.3 Biogen Adalimumab Injection Product and Services
    • 2.5.4 Biogen Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Biogen Recent Developments/Updates
  • 2.6 Celltrion
    • 2.6.1 Celltrion Details
    • 2.6.2 Celltrion Major Business
    • 2.6.3 Celltrion Adalimumab Injection Product and Services
    • 2.6.4 Celltrion Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Celltrion Recent Developments/Updates
  • 2.7 Cadila Pharmaceuticals
    • 2.7.1 Cadila Pharmaceuticals Details
    • 2.7.2 Cadila Pharmaceuticals Major Business
    • 2.7.3 Cadila Pharmaceuticals Adalimumab Injection Product and Services
    • 2.7.4 Cadila Pharmaceuticals Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Cadila Pharmaceuticals Recent Developments/Updates
  • 2.8 Bio-Thera Solutions, Ltd.
    • 2.8.1 Bio-Thera Solutions, Ltd. Details
    • 2.8.2 Bio-Thera Solutions, Ltd. Major Business
    • 2.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Product and Services
    • 2.8.4 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bio-Thera Solutions, Ltd. Recent Developments/Updates
  • 2.9 Hisun Biopharmaceutical
    • 2.9.1 Hisun Biopharmaceutical Details
    • 2.9.2 Hisun Biopharmaceutical Major Business
    • 2.9.3 Hisun Biopharmaceutical Adalimumab Injection Product and Services
    • 2.9.4 Hisun Biopharmaceutical Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hisun Biopharmaceutical Recent Developments/Updates
  • 2.10 Innovent Biologics
    • 2.10.1 Innovent Biologics Details
    • 2.10.2 Innovent Biologics Major Business
    • 2.10.3 Innovent Biologics Adalimumab Injection Product and Services
    • 2.10.4 Innovent Biologics Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Innovent Biologics Recent Developments/Updates
  • 2.11 Mylan
    • 2.11.1 Mylan Details
    • 2.11.2 Mylan Major Business
    • 2.11.3 Mylan Adalimumab Injection Product and Services
    • 2.11.4 Mylan Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Mylan Recent Developments/Updates
  • 2.12 Zydus Group
    • 2.12.1 Zydus Group Details
    • 2.12.2 Zydus Group Major Business
    • 2.12.3 Zydus Group Adalimumab Injection Product and Services
    • 2.12.4 Zydus Group Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zydus Group Recent Developments/Updates
  • 2.13 Boehringer Ingelheim
    • 2.13.1 Boehringer Ingelheim Details
    • 2.13.2 Boehringer Ingelheim Major Business
    • 2.13.3 Boehringer Ingelheim Adalimumab Injection Product and Services
    • 2.13.4 Boehringer Ingelheim Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
    • 2.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Details
    • 2.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
    • 2.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product and Services
    • 2.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
  • 2.15 Shanghai Henlius Biotech
    • 2.15.1 Shanghai Henlius Biotech Details
    • 2.15.2 Shanghai Henlius Biotech Major Business
    • 2.15.3 Shanghai Henlius Biotech Adalimumab Injection Product and Services
    • 2.15.4 Shanghai Henlius Biotech Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Shanghai Henlius Biotech Recent Developments/Updates

3 Competitive Environment: Adalimumab Injection by Manufacturer

  • 3.1 Global Adalimumab Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Adalimumab Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Adalimumab Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Adalimumab Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Adalimumab Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Adalimumab Injection Manufacturer Market Share in 2025
  • 3.5 Adalimumab Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Adalimumab Injection Market: Region Footprint
    • 3.5.2 Adalimumab Injection Market: Company Product Type Footprint
    • 3.5.3 Adalimumab Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Adalimumab Injection Market Size by Region
    • 4.1.1 Global Adalimumab Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Adalimumab Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Adalimumab Injection Average Price by Region (2021-2032)
  • 4.2 North America Adalimumab Injection Consumption Value (2021-2032)
  • 4.3 Europe Adalimumab Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Adalimumab Injection Consumption Value (2021-2032)
  • 4.5 South America Adalimumab Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Adalimumab Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Adalimumab Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Adalimumab Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Adalimumab Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Adalimumab Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Adalimumab Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Adalimumab Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Adalimumab Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Adalimumab Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Adalimumab Injection Market Size by Country
    • 7.3.1 North America Adalimumab Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Adalimumab Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Adalimumab Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Adalimumab Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Adalimumab Injection Market Size by Country
    • 8.3.1 Europe Adalimumab Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Adalimumab Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Adalimumab Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Adalimumab Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Adalimumab Injection Market Size by Region
    • 9.3.1 Asia-Pacific Adalimumab Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Adalimumab Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Adalimumab Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Adalimumab Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Adalimumab Injection Market Size by Country
    • 10.3.1 South America Adalimumab Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Adalimumab Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Adalimumab Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Adalimumab Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Adalimumab Injection Market Size by Country
    • 11.3.1 Middle East & Africa Adalimumab Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Adalimumab Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Adalimumab Injection Market Drivers
  • 12.2 Adalimumab Injection Market Restraints
  • 12.3 Adalimumab Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Adalimumab Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Adalimumab Injection
  • 13.3 Adalimumab Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Adalimumab Injection Typical Distributors
  • 14.3 Adalimumab Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Adalimumab Injection. Industry analysis & Market Report on Adalimumab Injection is a syndicated market report, published as Global Adalimumab Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Adalimumab Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo